Back to mobile site

AtriCure Inc. (ATRC) PT Raised to $65 by Stifel - Physicians Favor LAAM Technology

September 17, 2026 7:43 AM EDT Send to a Friend
Stifel analyst John McAulay reiterated a Buy rating and $65.00 price target on AtriCure Inc. (NASDAQ: ATRC).The analyst commented, "Since ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login